Drug Information

Drug General Information
Drug ID
D07TUX
Former ID
DNC007306
Drug Name
7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527353]
Formula
C14H12N2O3
Canonical SMILES
C1=CC(=CC2=C1C=CC(=O)O2)OCCN3C=CN=C3
InChI
1S/C14H12N2O3/c17-14-4-2-11-1-3-12(9-13(11)19-14)18-8-7-16-6-5-15-10-16/h1-6,9-10H,7-8H2
InChIKey
JUOCDQIZOPYANC-UHFFFAOYSA-N
PubChem Compound ID
11230598
Target and Pathway
Target(s) Cytochrome P450 19 Target Info Inhibitor [527353]
BioCyc Pathway Superpathway of steroid hormone biosynthesis
Estradiol biosynthesis II
Estradiol biosynthesis I
KEGG Pathway Steroid hormone biosynthesis
Metabolic pathways
Ovarian steroidogenesis
NetPath Pathway FSH Signaling Pathway
PANTHER Pathway Androgen/estrogene/progesterone biosynthesis
PathWhiz Pathway Androgen and Estrogen Metabolism
Reactome Endogenous sterols
WikiPathways Metapathway biotransformation
Tryptophan metabolism
Oxidation by Cytochrome P450
Ovarian Infertility Genes
Metabolism of steroid hormones and vitamin D
FSH signaling pathway
Integrated Breast Cancer Pathway
Phase 1 - Functionalization of compounds
References
Ref 527353J Med Chem. 2004 Dec 30;47(27):6792-803.Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.
Ref 527353J Med Chem. 2004 Dec 30;47(27):6792-803.Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.